# New Study Links Cannabis Vaping to Controversial Vomiting Syndrome > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-hyperemesis-syndrome-vaping-risks/ > **Published:** 2026-03-12T12:55:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:59:22-04:00 > **Clinical Summary:** Explore the link between cannabinoid hyperemesis syndrome vaping and severe vomiting. Learn about risks and clinical insights for cannabis users. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHC Why This Matters Clinicians should be aware that cannabis vaping may increase the risk of cannabinoid hyperemesis syndrome (CHS), a condition characterized by severe cyclic vomiting that can be debilitating and difficult to diagnose. Patients who present with unexplained nausea and vomiting should be systematically queried about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), particularly vaping methods, as this symptom pattern may improve with cannabis cessation rather than standard antiemetic treatments. This evidence helps clinicians differentiate CHS from other causes of recurrent vomiting and allows for appropriate patient counseling regarding the hyperemetic risks associated with [cannabis consumption methods](https://cedclinic.com/cannabis-anxiety-relief-tips/). Clinical Summary A new study published in Cannabis and [Cannabinoid Research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) identifies a clinical association between cannabis vaping and cannabinoid hyperemesis syndrome (CHS), a condition characterized by severe, cyclic vomiting that can significantly impair patient quality of life. The research adds to existing evidence linking cannabinoid use to CHS, though the specific mechanisms remain incompletely understood and may relate to dose, frequency, potency, or individual susceptibility factors. This finding is particularly relevant given the rising prevalence of high-potency vaping products in the market, which deliver concentrated cannabinoids and may pose greater CHS risk than traditional cannabis preparations. Clinicians should maintain awareness of CHS as a potential diagnosis in patients presenting with intractable nausea and vomiting, particularly those reporting regular cannabis use, and should counsel patients about this risk during the informed consent discussion before recommending [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). Patients who develop recurrent vomiting associated with cannabis use should be advised that cessation remains the only definitively effective treatment, though symptom management with antiemetics and hydration may provide interim relief. Clinicians should screen patients for CHS symptoms and discuss this emerging adverse effect when evaluating cannabis use in symptomatic patients to enable shared decision-making. Dr. Caplan’s Take “Cannabinoid hyperemesis syndrome is real and I see it regularly in my practice, typically in heavy daily users who vape high-potency products, and the key clinical point that gets missed is that stopping cannabis completely is the only effective treatment—no antiemetic works until they abstain.” Clinical Perspective Cannabinoid hyperemesis syndrome represents a paradoxical clinical entity wherein regular, high-potency cannabis use—particularly through vaping—precipitates severe, cyclic vomiting that often resolves only with cannabis cessation. While the underlying mechanism remains incompletely understood, emerging evidence suggests a dose-dependent relationship between cannabinoid exposure and symptom severity, though individual susceptibility factors and the specific cannabinoid profile of products (THC concentration, presence of CBD, terpenes) likely play important confounding roles. Healthcare providers should maintain clinical suspicion for CHS in patients presenting with intractable nausea and vomiting, especially those reporting frequent or high-dose cannabis use, as the condition is frequently misdiagnosed and may lead to unnecessary investigations and treatments. Practically, screening for cannabis use patterns—including frequency, potency, and consumption method—should become routine in patients with refractory n 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+New+study+links+cannabis+vaping+to+controversial+vomiting+syndrome+%7C+GreenState+%40drcaplan&url=https%3A%2F%2Fwww.greenstate.com%2Fnews%2Fcannabis-vapes-chs%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.greenstate.com%2Fnews%2Fcannabis-vapes-chs%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+New+study+links+cannabis+vaping+to+controversial+vomiting+syndrome+%7C+GreenState+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.greenstate.com%2Fnews%2Fcannabis-vapes-chs%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.greenstate.com/news/cannabis-vapes-chs/](https://www.greenstate.com/news/cannabis-vapes-chs/) Further Reading Research Digest[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/) Evidence Watch[Cannabinoid Clinical Trials: CBD Cortical Excitability Study](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/) Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 12, 2026](https://cedclinic.com/cannabis-regulatory-updates-march-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [New Calif. study links cannabis vaping to violent vomiting syndrome – Yahoo](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-vaping-risks/) This article discusses a California study that highlights the connection between cannabis vaping and severe vomiting syndromes, providing additional clinical context. [Read More](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-vaping-risks/) [Cannabis Hyperemesis Syndrome cases rise nationwide as providers warn of growing …](https://cedclinic.com/cannabis-hyperemesis-syndrome-cases-surge-nationwide/) Explore the nationwide increase in cannabinoid hyperemesis syndrome cases and expert warnings about this emerging health concern. [Learn More](https://cedclinic.com/cannabis-hyperemesis-syndrome-cases-surge-nationwide/) [Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com](https://cedclinic.com/cannabis-hyperemesis-syndrome-clinical-overview/) This resource outlines the symptoms of cannabinoid hyperemesis syndrome and offers guidance on recognizing this condition early. [Discover Symptoms](https://cedclinic.com/cannabis-hyperemesis-syndrome-clinical-overview/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).